Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

MiR-200 overexpression in colorectal cancer lines


ABSTRACT: Unsupervised classification of gene expression profiles has resulted in the identification of biologically and clinically distinct colon cancer subtypes (CCSs). The subtype that associates with poor clinical outcome displays a mesenchymal gene expression profile. No driver mutation has been identified for this category and patients are heterogeneous with regard to commonly used clinical markers. Here we report a regulatory network consisting of the miR-200 family members that tunes the majority of genes differentially expressed in the poor prognosis CCS, including genes involved in the epithelial-mesenchymal transition (EMT) process. Our data indicate that the epigenetic silencing of the miR-200 family by promoter methylation is identifying the mesenchymal CCS and is predictive of disease-free survival in this malignancy. We demonstrate that the molecular features of poor prognosis colon cancer - expression of EMT-associated genes and miR-200 promoter methylation - can already be installed at the premalignant stage, suggesting a highly malignant potential of specific colon cancer precursor lesions. Four colorectal cancer cell lines that display methylated miR-200 loci have been used to overexpress miR-200 family members from both loci separatedly or simultaneously.

ORGANISM(S): Homo sapiens

SUBMITTER: Louis Vermeulen 

PROVIDER: E-GEOD-65551 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2015-09-01 | GSE65551 | GEO
2018-11-07 | E-MTAB-6717 | biostudies-arrayexpress
2016-12-30 | E-MTAB-5033 | biostudies-arrayexpress
2018-10-31 | GSE113162 | GEO
2013-11-20 | E-GEOD-37596 | biostudies-arrayexpress
2021-09-09 | PXD018052 | Pride
2016-07-03 | E-GEOD-72767 | biostudies-arrayexpress
2016-08-15 | E-GEOD-71756 | biostudies-arrayexpress
2015-08-06 | PXD001998 | Pride
2009-11-28 | E-GEOD-15741 | biostudies-arrayexpress